Supported by Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz,No.NC23189.0.
In recent years,cancer immunotherapy has introduced novel treatments,such as monoclonal antibodies,which have facilitated targeted therapies against tumor cells.Programmed death-1(PD-1)is an immune checkpoint expresse...
supported by the Key Program,National Natural Science Foundation of China(No.81930016);National Key Research and Development Program of China(No.2021YFA1100500);Key Research&Development Plan of Zhejiang Province(No.2019C03050);Construction Fund of Key Medical Disciplines of Hangzhou(OO20200093);Key Research&Development Plan of Zhejiang Province(No.2021C03118),Projects of Medical and Health Technology Program in Zhejiang Province(WKJ-ZJ-2120);National Natural Science Foundation of China(No.82273177,No.12304256);Natural Science Foundation of Zhejiang Province(LY22H160046,LQ24C050005);Key Research and Development Plan of Zhejiang Province(2022C03108).Joint Funds of the National Natural Science Foundation of China(No.U23A20451).
Hepatocellular carcinoma(HCC)is a highly malignant tumor with significant global health implications.The role of CD4+T cells,particularly conventional CD4+T cells(Tconvs),in HCC progression remains unexplored.Furtherm...
supported by the National Key R&D Program of China(No.2020YFA0710802 to Jiacheng Bi);Guangdong Basic and Applied Basic Research Foundation(No.2021A1515110174 to Yingying Huang);the National Natural Science Foundation of China(No.82071768 to Jiacheng Bi).
Natural killer(NK)cells are key innate immune lymphocytes,which play important roles against tumors.However,tumor-infiltrating NK cells are always hypofunctional/exhaustive.On the one hand,this state is contributed by...
supported by the National Natural Science Foundation of China (Grant Nos.U22A2046,52172322,and U1934219);the Science and Technology Research Development Plan of China Railway Corporation (Grant Nos.L2021G003 and L2022G010);the State Key Laboratory of Rail Traffic Control and Safety (Grant No.RCS2022ZZ003);the Fundamental Research Funds for the Central Universities (Grant No.2022JBQY001);the National Science Fund for Excellent Young Scholars (Grant No.52022010)。
With rising energy prices and concerns about environmental issues,energy-efficient driving strategies(EEDS)for high-speed trains have received a substantial amount of attention.In particular,energy-saving schemes play...
supported by the National Natural Science Foundation of China(Grant Nos.82203539 and 92259102);Provincial Cooperation Project of Science and Technology Department of Sichuan Province(Grant No.2023YFSY0043);the National Key Research and Development Program of China(Grant No.2023YFC3402100).
Immune checkpoint inhibitors(ICIs)are used to relieve and refuel anti-tumor immunity by blocking the interaction,transcription,and translation of co-inhibitory immune checkpoints or degrading co-inhibitory immune chec...
Immune checkpoint inhibitors(and more specifically programmed cell death 1/programmed cell death ligand 1 inhibitors as Pembrolizumab)initiated a revolution in the field of melanoma and have now expanded to several tu...
Objective To investigate the anti-tumor effects of Pien Tze Huang(PZH)in mouse models of B16–F10 melanoma,MC38 colorectal cancer,Hep1-6 hepatocellular carcinoma and chemically induced hepatocellular carcinoma model.M...
supported by the National Natural Science Foundation of China(Nos.U21A20421,82073882,82073317,81772540 and 82272996);the Key Project of Science Technology Program of Guangzhou(No.2023B03J0029,China);the National Key R&D Program of China(No.2022YFE0209700);the Science and Technology Program of Guangzhou(Nos.202201010819 and 202206010081,China)。
Cancer immunotherapy,exemplified by the remarkable clinical benefits of the immune checkpoint blockade and chimeric antigen receptor T-cell therapy,is revolutionizing cancer therapy.They induce long-term tumor regress...